|
| Home : Invizius Awarded Second Biomedical Catalyst Grant to Research Peritoneal Dialysis Option for its H-Guard® Technology |
|
Apr 26
2022 |
Invizius Awarded Second Biomedical Catalyst Grant to Research Peritoneal Dialysis Option for its H-Guard® Technology |
|
GLASGOW, Scotland, April 26, 2022 /PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing treatments to suppress unwanted immune responses in haemodialysis, today announces that it has been awarded a second Biomedical Catalyst grant (Feasibility & Primer Award)... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/invizius-awarded-second-biomedical-catalyst-grant-to-research-peritoneal-dialysis-option-for-its-h-guard-technology-301532189.html |
| |
|
Related News
|
» MetaTag launches NFT usernames for gamers
» Compliancy Group Launches Sales Enablement Program for MSPs
|
|
|
